BioCentury
ARTICLE | Financial News

Cerus files shelf

August 10, 2001 7:00 AM UTC

CERS filed a shelf registration statement covering the sale of up to $300 million worth of common stock and debt securities. CERS, which is developing systems for inactivating pathogens in blood produ...